A Study of DTC in Patients With AIDS and AIDS Related Complex
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To determine if ditiocarb sodium (sodium diethyldithiocarbamate; DTC) restores immune and
host defense function; if DTC ameliorates the AIDS related complex (ARC) symptoms in patients
with AIDS and ARC; if DTC prevents progression from ARC to AIDS or progression of AIDS; and
if DTC prolongs survival in AIDS.